Active8: A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination With TLR8 Agonist VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-s3-p69
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Cetuximab Plus Platinum-Based Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Randomized, Double-Blind Safety Study Comparing Cetuximab Produced From Two Manufacturing Processes Using the EXTREME Study Regimen

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma

Oral Oncology
Cancer ResearchOral SurgeryOncology
2013English

Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma

Journal of Clinical Investigation
Medicine
2016English

Pcn105 - Economic Burden of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Nivolumab in the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (RM-SCCHN): A Report of 16 Cases at a Single Institution

International Journal of Practical Otolaryngology
2019English

Socioeconomic Factors and Survival in Patients With Non-Metastatic Head and Neck Squamous Cell Carcinoma

Cancer Science
Cancer ResearchMedicineOncology
2017English

A Phase I Dose Escalation Trial of MAGE-A3 and HPV-16 Specific Peptide Immunomodulatory Vaccines in Patients With Recurrent/Metastatic (RM) Squamous Cell Carcinoma of the Head and Neck (SCCHN).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

SUPREME-HN: A Retrospective Biomarker Study Assessing the Prognostic Value of PD-L1 Expression in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy